Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cool Prime Comparative Effectiveness Study for Mild HIE
Sponsor: University of Texas Southwestern Medical Center
Summary
To determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with mild HIE. To determine the adverse effects of Therapeutic Hypothermia (TH) in mild HIE on the neonate and his/her family. Determine heterogeneity of the treatment effect across key subgroups obtained in the first 6 hours after birth prior to the decision to initiate therapy.
Official title: COOLPRIME: Comparative Effectiveness for Cooling Prospectively Infants With Mild Encephalopathy
Key Details
Gender
All
Age Range
36 Weeks - Any
Study Type
OBSERVATIONAL
Enrollment
460
Start Date
2023-07-19
Completion Date
2029-01-01
Last Updated
2025-12-08
Healthy Volunteers
No
Interventions
Normothermia
Usual care for first 72 hours for neonates with mild encephalopathy maintaining core temperature (36.5°C ± 1 C).
Whole body therapeutic hypothermia
Whole-body therapeutic hypothermia (33.5°C ± 0.5°C) for 72 hours began by 6 hours of age for neonates with mild encephalopathy per site standard of care practice.
Locations (1)
University of Texas Southwestern Medical Center
Dallas, Texas, United States